Back
Speaker illustration

undefined undefined undefined

Presentations

A novel dual-action insulin secreting and natriuretic peptide, CRRL 101, a potential therapy for diabetic cardiomyopathy

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Chronic heart failure - treatment 9

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources